“AIDS is Not a Business”: A Study in Global Corporate Responsibility – Securing Access to Low-Cost HIV Medications

At the end of the 1990s, Brazil was faced with a potentially explosive HIV/AIDS epidemic. Through an innovative and multifaceted campaign, and despite initial resistance from multinational pharmaceutical companies, the government of Brazil was able to negotiate price reductions for HIV medications and develop local production capacity, thereby averting a public health disaster. Using interview data and document analysis, the authors show that the exercise of corporate social responsibility can be viewed in practice as a dynamic negotiation and an interaction between multiple actors. Action undertaken in terms of voluntary CSR alone may be insufficient. This finding highlights the importance of a strong role for national governments and international organizations to pressure companies to perform better.

“AIDS Is Not a Business”: A Study in Global Corporate Responsibility – Securing Access to Low-Cost HIV Medications’, WilliamFlanagan and GailWhitemanJournal of Business Ethics, 73 (2007): 65–75. © Springer 2006. Reprinted with kind permission from Springer Science +Business Media via Copyright Clearance Center's Rightslink service.
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles